Granulocytes as effectors in cell-mediated cytotoxicity of adherent target cells.

In the microassay for cell-mediated immunity, detachment of adherent target cells from the wells occurs to an even greater extent when tested with granulocytes than when tested with lymphocytes. Intact cells are not necessary since the sonic extract from granulocytes causes the same effect. The reaction by granulocytes appears to be mediated by enzymes, and is inhibited by the presence in the wells of hyaluronic acid. Moreover, it is limited to the detachment of adherent target cells, since neither intact nor sonically disrupted granulocytes exhibit cytotoxic activity in the chromium release assay. The detachment of target cells is also inhibited by heparin which may be used to specifically mullify the effect of granulocytes contaminating lymphocyte suspensions.

[1]  M. R. Mickey,et al.  Studies on specificity of cell-mediated immunity to human tumors. , 1974, Journal of the National Cancer Institute.

[2]  S. Brosman,et al.  Cell‐mediated cytotoxicity against human bladder cancer , 1974, International journal of cancer.

[3]  H. Oettgen,et al.  Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: Detection by A 3H‐proline microcytotoxicity test , 1974, International journal of cancer.

[4]  E. Saksela,et al.  Cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer. , 1973, Journal of the National Cancer Institute.

[5]  R. W. Baldwin,et al.  Cell‐mediated and humoral immune reactions to human tumours , 1973, International journal of cancer.

[6]  J. Sinkovics,et al.  Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity. , 1973, National Cancer Institute monograph.

[7]  M. R. Mickey,et al.  Quantitation of the microassay for cell-mediated immunity through electronic image analysis. , 1973, National Cancer Institute monograph.

[8]  G. Heppner,et al.  Cell‐mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma , 1973, International journal of cancer.

[9]  D. Morton,et al.  Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen. , 1973, Journal of the National Cancer Institute.

[10]  M. R. Mickey,et al.  Allogeneic cell-mediated testing for human tumor antigens. , 1972, National Cancer Institute monograph.

[11]  N. Cascinelli,et al.  Cellular and humoral immunity against human malignant melanoma , 1971, International journal of cancer.

[12]  R. H. Tew,et al.  In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Diehl,et al.  Cellular immunity to nephroblastoma , 1971, International journal of cancer.

[14]  H. Sjögren,et al.  Demonstration of cell‐mediated immunity to human neoplasms of various histological types , 1971, International journal of cancer.

[15]  E. Klein,et al.  23 – THE METHODOLOGY OF MICROASSAY FOR CELL-MEDIATED IMMUNITY (MCI) , 1971 .

[16]  P. Disaia,et al.  Cell‐mediated immune reaction to two gynecologic malignant tumors , 1971, Cancer.

[17]  K. Hellström,et al.  Studies on cellular immunity to human neuroblastoma cells , 1970, International journal of cancer.

[18]  E. Klein,et al.  A MICROASSAY FOR CELL-MEDIATED IMMUNITY , 1970, Transplantation.

[19]  P. Perlmann,et al.  Immune response to urinary bladder tumours in man , 1970, International journal of cancer.

[20]  C. Zukoski,et al.  Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. , 1968, Clinical and experimental immunology.

[21]  A. Bøyum,et al.  Separation of leukocytes from blood and bone marrow. Introduction. , 1968 .